Autonomous
发表于 2025-3-21 19:46:45
书目名称Alternating Electric Fields Therapy in Oncology影响因子(影响力)<br> http://figure.impactfactor.cn/if/?ISSN=BK0154023<br><br> <br><br>书目名称Alternating Electric Fields Therapy in Oncology影响因子(影响力)学科排名<br> http://figure.impactfactor.cn/ifr/?ISSN=BK0154023<br><br> <br><br>书目名称Alternating Electric Fields Therapy in Oncology网络公开度<br> http://figure.impactfactor.cn/at/?ISSN=BK0154023<br><br> <br><br>书目名称Alternating Electric Fields Therapy in Oncology网络公开度学科排名<br> http://figure.impactfactor.cn/atr/?ISSN=BK0154023<br><br> <br><br>书目名称Alternating Electric Fields Therapy in Oncology被引频次<br> http://figure.impactfactor.cn/tc/?ISSN=BK0154023<br><br> <br><br>书目名称Alternating Electric Fields Therapy in Oncology被引频次学科排名<br> http://figure.impactfactor.cn/tcr/?ISSN=BK0154023<br><br> <br><br>书目名称Alternating Electric Fields Therapy in Oncology年度引用<br> http://figure.impactfactor.cn/ii/?ISSN=BK0154023<br><br> <br><br>书目名称Alternating Electric Fields Therapy in Oncology年度引用学科排名<br> http://figure.impactfactor.cn/iir/?ISSN=BK0154023<br><br> <br><br>书目名称Alternating Electric Fields Therapy in Oncology读者反馈<br> http://figure.impactfactor.cn/5y/?ISSN=BK0154023<br><br> <br><br>书目名称Alternating Electric Fields Therapy in Oncology读者反馈学科排名<br> http://figure.impactfactor.cn/5yr/?ISSN=BK0154023<br><br> <br><br>
彩色
发表于 2025-3-21 22:02:13
Fundamental Physics of Tumor Treating Fields,. Recently, the anticancer Tumor Treating Fields (TTFields), which are alternating electric fields applied according to the principles of Maxwell’s equations of electromagnetism, has made available a novel method of treating patients with glioblastomas, brain metastases, and certain systemic maligna
ALERT
发表于 2025-3-22 03:21:28
Biophysical Effects of Tumor Treating Fields, theoretical investigations lead to numerous cell characterization and manipulation techniques which were translated into clinical applications. Low-frequency alternating current (AC) fields are employed for nerve and muscle stimulation, while high-frequency fields find medical relevance in tissue h
蒙太奇
发表于 2025-3-22 07:26:34
Computer Simulation of Tumor Treating Fields,ents. TTFields are alternating electric fields at 200 kHz continuously delivered by the Optune device to the scalp of patients. Preclinical experiments have shown that they interfere with dividing cancer cells as they undergo metaphase-to-anaphase transition in mitosis and, specifically, they disrup
恃强凌弱
发表于 2025-3-22 09:49:22
Response Pattern and Modeling of Tumor Treating Fields,. The Optune device represents an innovative treatment option for patients with recurrent GBM, which utilizes alternating electric fields at an intermediate frequency of 200 kHz, or Tumor Treating Fields (TTFields), to selectively kill or arrest the growth of rapidly dividing cells. Approximately 15
令人悲伤
发表于 2025-3-22 14:47:08
Clinical Efficacy of Tumor Treating Fields for Recurrent Glioblastoma, criteria but the extent of the tumor is much larger than that can be seen on neuroimaging. Patient prognosis is poor and survival is short. The Optune device is an FDA-approved treatment for recurrent glioblastoma and it uses Tumor Treating Fields (TTFields) to disrupt tumor cells as they undergo m
cardiopulmonary
发表于 2025-3-22 20:28:57
http://reply.papertrans.cn/16/1541/154023/154023_7.png
最小
发表于 2025-3-23 00:22:57
Tumor Treating Fields Therapy for Newly Diagnosed Glioblastoma, within the tumor microenvironment. These inter-tumoral and intra-tumoral heterogeneities are what make glioblastomas so difficult to treat in patients. As the tumor progresses over time, it accumulates more alterations and co-opts normal physiological processes for growth and proliferation as well
闲逛
发表于 2025-3-23 04:33:42
http://reply.papertrans.cn/16/1541/154023/154023_9.png
惰性女人
发表于 2025-3-23 07:08:45
Future Directions for Tumor Treating Fields,d glioblastoma since receiving FDA approvals in 2011 and 2015, respectively. Where this treatment modality goes from here is currently a subject of intensive clinical investigations. For glioblastoma, TTFields are being combined with stereotactic radiosurgery, hypofractionated radiation, bevacizumab